<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02739269</url>
  </required_header>
  <id_info>
    <org_study_id>UW 12-358</org_study_id>
    <nct_id>NCT02739269</nct_id>
  </id_info>
  <brief_title>Antimullerian Hormone Versus Antral Follicle Count for Determination of Gonadotrophin Dosing in IVF</brief_title>
  <official_title>A Randomised Trial to Compare Antral Follicle Count and Serum Anti-Mullerian Hormone Level for Determination of Gonadotrophin Dosing in In-vitro Fertilisation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized trial to compare the use of AFC and serum AMH as the basis
      for gonadotrophin dosing in in-vitro fertilization treatment.

      The hypothesis is that the use of serum AMH as the criterion for determination of
      gonadotrophin dosing in IVF treatment results in more optimal ovarian response than AFC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing the first-time IVF treatment cycle using either conventional insemination
      technique or intracytoplasmic sperm injection at Queen Mary Hospital will be invited to
      participate in this study. Participating subjects will be randomized into either (i) AFC or
      (ii) AMH group, where the gonadotrophin dosing will be determined based on the baseline AFC
      and serum AMH respectively as assessed one month before the IVF treatment. Randomisation will
      be performed according to a computer-generated list which will be read by an independent
      research nurse. That research nurse will assign the initial gonadotrophin dose according to
      the study protocol.

      In the AFC group, starting dose of gonadotrophin will be determined based on serum AMH
      concentration as follows:

      AFC &lt;= 5: 300 IU daily AFC &gt;5 and &lt;=15: 225 IU daily AFC &gt;15: 150 IU daily

      In the AMH group, starting dose of gonadotrophin will be determined based on serum AMH
      concentration as follows:

      AMH &lt;= 1.0 ng/ml: 300 IU daily AMH &gt;1.0 and &lt;=3.3 ng/ml: 225 IU daily AMH &gt;3.3 ng/ml: 150 IU
      daily

      The clinician and patient will both be blinded to the randomization throughout the course of
      treatment. The proportion of subjects having appropriate ovarian response, defined as the
      number of oocytes retrieved being 6 to 14 inclusive, will be compared between the two arms.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of subjects having appropriate ovarian response</measure>
    <time_frame>One single time point, i.e. at the time of oocyte retrieval</time_frame>
    <description>Percentage of subjects with number of oocytes retrieved being between 6 and15</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects requiring step-up or step-down of gonadotrophin dose upon first ultrasound tracking</measure>
    <time_frame>7th day of ovarian stimulation</time_frame>
    <description>The dose of gonadotrophin will be adjusted according to the ovarian response: if 5 or less follicles growing beyond 10 mm --&gt; step up if more than 15 follicles growing beyond 10 mm --&gt; step down</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>AMH group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Serum AMH measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AFC group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>AFC measurement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Serum AMH measurement</intervention_name>
    <description>Serum AMH is measured one month before the IVF treatment</description>
    <arm_group_label>AMH group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>AFC measurement</intervention_name>
    <description>Early follicular phase AFC is measured one month before the IVF treatment</description>
    <arm_group_label>AFC group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects undergoing the first IVF cycle during the study period.

        Exclusion Criteria:

          -  Body mass index &gt;=30 kg/m2

          -  Subjects in repeated IVF cycles

          -  Subjects undergoing IVF treatment using donor oocytes

          -  Subjects undergoing pre-implantation genetic diagnosis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hang Wun Raymond Li, MBBS, FRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hang Wun Raymond Li, MBBS, FRCOG</last_name>
    <phone>+852 22553914</phone>
    <email>raymondli@hku.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ernest Hung Yu Ng, MD, FRCOG</last_name>
    <phone>+852 22553400</phone>
    <email>nghye@hku.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hang Wun Raymond Li, MBBS, FRCOG</last_name>
      <phone>+852 22553914</phone>
      <email>raymondli@hku.hk</email>
    </contact>
    <contact_backup>
      <last_name>Ernest Hung Yu Ng, MD, FRCOG</last_name>
      <phone>+852 22554700</phone>
      <email>nghye@hku.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Hang Wun Raymond Li, MBBS, FRCOG</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2016</study_first_submitted>
  <study_first_submitted_qc>April 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2016</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Dr. Hang Wun Raymond Li</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>ovarian response</keyword>
  <keyword>anti-Mullerian hormone</keyword>
  <keyword>antral follicle count</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>No such plan at the moment</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>May 19, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

